Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Targeting cancer cell integrins using gold nanorods in photothermal therapy inhibits migration through affecting cytoskeletal proteins.

Ali MRK, Wu Y, Tang Y, Xiao H, Chen K, Han T, Fang N, Wu R, El-Sayed MA.

Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):E5655-E5663. doi: 10.1073/pnas.1703151114. Epub 2017 Jun 26.

PMID:
28652358
2.

A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.

Liu D, Zhou D, Wang B, Knabe WE, Meroueh SO.

ACS Chem Biol. 2015 Jun 19;10(6):1521-34. doi: 10.1021/cb500832q. Epub 2015 Mar 31.

3.

Biologically-active laminin-111 fragment that modulates the epithelial-to-mesenchymal transition in embryonic stem cells.

Horejs CM, Serio A, Purvis A, Gormley AJ, Bertazzo S, Poliniewicz A, Wang AJ, DiMaggio P, Hohenester E, Stevens MM.

Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):5908-13. doi: 10.1073/pnas.1403139111. Epub 2014 Apr 3.

4.

Integrin α3β1 controls mRNA splicing that determines Cox-2 mRNA stability in breast cancer cells.

Subbaram S, Lyons SP, Svenson KB, Hammond SL, McCabe LG, Chittur SV, DiPersio CM.

J Cell Sci. 2014 Mar 15;127(Pt 6):1179-89. doi: 10.1242/jcs.131227. Epub 2014 Jan 16.

5.

Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins.

Yang J, Wheeler SE, Velikoff M, Kleaveland KR, LaFemina MJ, Frank JA, Chapman HA, Christensen PJ, Kim KK.

Am J Pathol. 2013 Nov;183(5):1559-70. doi: 10.1016/j.ajpath.2013.07.016. Epub 2013 Sep 5.

6.

Integrins and cAMP mediate netrin-induced growth cone collapse.

Lemons ML, Abanto ML, Dambrouskas N, Clements CC, Deloughery Z, Garozzo J, Condic ML.

Brain Res. 2013 Nov 6;1537:46-58. doi: 10.1016/j.brainres.2013.08.045. Epub 2013 Aug 31.

7.
8.

Role of urokinase receptor in tumor progression and development.

Noh H, Hong S, Huang S.

Theranostics. 2013 Jun 25;3(7):487-95. doi: 10.7150/thno.4218. Print 2013. Review.

9.

The plasminogen system in regulating stem cell mobilization.

Gong Y, Hoover-Plow J.

J Biomed Biotechnol. 2012;2012:437920. doi: 10.1155/2012/437920. Epub 2012 Oct 14. Review.

10.

VEGF-initiated angiogenesis and the uPA/uPAR system.

Breuss JM, Uhrin P.

Cell Adh Migr. 2012 Nov-Dec;6(6):535-615. doi: 10.4161/cam.22243. Epub 2012 Oct 17. Review.

11.

Axin pathway activity regulates in vivo pY654-β-catenin accumulation and pulmonary fibrosis.

Ulsamer A, Wei Y, Kim KK, Tan K, Wheeler S, Xi Y, Thies RS, Chapman HA.

J Biol Chem. 2012 Feb 10;287(7):5164-72. doi: 10.1074/jbc.M111.322123. Epub 2011 Dec 27.

12.

Two distinct integrin-mediated mechanisms contribute to apical lumen formation in epithelial cells.

Myllymäki SM, Teräväinen TP, Manninen A.

PLoS One. 2011 May 6;6(5):e19453. doi: 10.1371/journal.pone.0019453.

13.

An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo.

Rabbani SA, Ateeq B, Arakelian A, Valentino ML, Shaw DE, Dauffenbach LM, Kerfoot CA, Mazar AP.

Neoplasia. 2010 Oct;12(10):778-88.

14.

Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.

Nalla AK, Asuthkar S, Bhoopathi P, Gujrati M, Dinh DH, Rao JS.

PLoS One. 2010 Sep 24;5(9):e13006. doi: 10.1371/journal.pone.0013006.

15.

The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.

Taylor MA, Parvani JG, Schiemann WP.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):169-90. doi: 10.1007/s10911-010-9181-1. Epub 2010 May 15. Review.

16.

Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.

Ghosh S, Koblinski J, Johnson J, Liu Y, Ericsson A, Davis JW, Shi Z, Ravosa MJ, Crawford S, Frazier S, Stack MS.

Mol Cancer Res. 2010 Feb;8(2):145-58. doi: 10.1158/1541-7786.MCR-09-0045. Epub 2010 Feb 9.

17.

Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.

Czekay RP, Loskutoff DJ.

J Cell Physiol. 2009 Sep;220(3):655-63. doi: 10.1002/jcp.21806.

18.

Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins.

Zhu S, Gladson CL, White KE, Ding Q, Stewart J Jr, Jin TH, Chapman HA Jr, Olman MA.

Am J Physiol Lung Cell Mol Physiol. 2009 Jul;297(1):L97-108. doi: 10.1152/ajplung.90283.2008. Epub 2009 May 1.

19.

Aberrant cell adhesion molecule expression in human bronchopulmonary sequestration and congenital cystic adenomatoid malformation.

Volpe MV, Chung E, Ulm JP, Gilchrist BF, Ralston S, Wang KT, Nielsen HC.

Am J Physiol Lung Cell Mol Physiol. 2009 Jul;297(1):L143-52. doi: 10.1152/ajplung.90618.2008. Epub 2009 May 1.

20.

Coordinate integrin and c-Met signaling regulate Wnt gene expression during epithelial morphogenesis.

Liu Y, Chattopadhyay N, Qin S, Szekeres C, Vasylyeva T, Mahoney ZX, Taglienti M, Bates CM, Chapman HA, Miner JH, Kreidberg JA.

Development. 2009 Mar;136(5):843-53. doi: 10.1242/dev.027805. Epub 2009 Jan 28.

Supplemental Content

Support Center